Medicare Cuts Payment to 774 Hospitals Over Patient Complications
(By Jordan Rau for Kaiser Health News) The federal government has penalized 774 hospitals for having the highest rates of
Read More
Health Care Finance
Cap on hospital rates carries bigger savings reward than price transparency, study finds
(By Alia Paavola for Becker’s Hospital Review) Setting hospital prices for commercial payers could achieve greater savings than other strategies like
Read MoreAn average out-of-pocket cost over $1,000 for serious cases of COVID-19
A new study suggests an average-out-of-pocket cost of over $1000 for serious cases of COVID-19 as insurers end grace period
Read MoreModest increase in drug costs can lead to increase in mortality
Cost-sharing can affect patient choices and, ultimately, patient health according to a new study by the National Board of Economic
Read MoreHow much Medicare claims dropped at start of pandemic
(By Morgan Haefner for Becker’s Hospital Review) Most U.S. health systems saw a reduction in elective procedures in the spring of
Read MorePrice Increases Continue to Outpace Inflation for Many Medicare Part D Drugs
(Juliette Cubanski and Tricia Neuman for Kaiser Family Foundation published February 4, 2021) In response to strong public support for
Read More40% of commercially insured patients incur half of yearly out-of-pocket spending in 1 visit
(By Katie Adams for Becker’s Hospital Review) Nearly 40 percent of all commercially insured patients acquire half of their annual out-of-pocket medical
Read MorePolicy options that could extend the solvency of the Medicare Hospital Insurance Trust Fund.
The Medicare Hospital Insurance (HI) Trust Fund also known as Medicare Part A, which is mainly funded through payroll taxes
Read MoreHHS agrees to delay drug rebate rule
(By Maia Anderson for Becker’s Hospital Review) HHS has agreed to postpone by one year the start date of a rule
Read MoreFour approaches the new Congress should take to rein in prescription drug costs
The new Congress should with a renewed legislative effort rein in prescription drug costs by targeting antitrust abuses is the
Read More